Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 37347737)

  • 1. Long non-coding RNAs CCAT1 and CCAT2 in colorectal liver metastases are tumor-suppressive via MYC interaction and might predict patient outcomes.
    Franz C; Wuehrl M; Hartmann S; Klupp F; Schmidt T; Schneider M
    PLoS One; 2023; 18(6):e0286486. PubMed ID: 37347737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CCAT1 and CCAT2 long noncoding RNAs, located within the 8q.24.21 'gene desert', serve as important prognostic biomarkers in colorectal cancer.
    Ozawa T; Matsuyama T; Toiyama Y; Takahashi N; Ishikawa T; Uetake H; Yamada Y; Kusunoki M; Calin G; Goel A
    Ann Oncol; 2017 Aug; 28(8):1882-1888. PubMed ID: 28838211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancer-derived long non-coding RNAs CCAT1 and CCAT2 at rs6983267 has limited predictability for early stage colorectal carcinoma metastasis.
    Thean LF; Blöcker C; Li HH; Lo M; Wong M; Tang CL; Tan EKW; Rozen SG; Cheah PY
    Sci Rep; 2021 Jan; 11(1):404. PubMed ID: 33432117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-coding RNA CCAT1 is a prognostic biomarker for the progression of oral squamous cell carcinoma via miR-181a-mediated Wnt/β-catenin signaling pathway.
    Li GH; Ma ZH; Wang X
    Cell Cycle; 2019 Nov; 18(21):2902-2913. PubMed ID: 31599709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knockdown of long non‑coding RNA CCAT2 suppresses the progression of thyroid cancer by inhibiting the Wnt/β‑catenin pathway.
    Xin S; Ye X
    Int J Mol Med; 2020 Dec; 46(6):2047-2056. PubMed ID: 33125134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-Myc-activated long noncoding RNA CCAT1 promotes colon cancer cell proliferation and invasion.
    He X; Tan X; Wang X; Jin H; Liu L; Ma L; Yu H; Fan Z
    Tumour Biol; 2014 Dec; 35(12):12181-8. PubMed ID: 25185650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of the c-MYC oncogene and adjacent long noncoding RNAs PVT1 and CCAT1 in esophageal squamous cell carcinoma.
    Roohinejad Z; Bahramian S; Shamsabadi FT; Sahebi R; Amini A; Sabour D; Shafiee M
    BMC Cancer; 2023 Jan; 23(1):34. PubMed ID: 36624401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. To Wnt or Lose: The Missing Non-Coding Linc in Colorectal Cancer.
    Shen P; Pichler M; Chen M; Calin GA; Ling H
    Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28930145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNA CCAT2 promotes cell proliferation and invasion through regulating Wnt/β-catenin signaling pathway in clear cell renal cell carcinoma.
    Huang JL; Liao Y; Qiu MX; Li J; An Y
    Tumour Biol; 2017 Jul; 39(7):1010428317711314. PubMed ID: 28718366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The long non-coding RNA CCAT2 is up-regulated in ovarian cancer and associated with poor prognosis.
    Huang S; Qing C; Huang Z; Zhu Y
    Diagn Pathol; 2016 Jun; 11(1):49. PubMed ID: 27283598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer.
    Ling H; Spizzo R; Atlasi Y; Nicoloso M; Shimizu M; Redis RS; Nishida N; Gafà R; Song J; Guo Z; Ivan C; Barbarotto E; De Vries I; Zhang X; Ferracin M; Churchman M; van Galen JF; Beverloo BH; Shariati M; Haderk F; Estecio MR; Garcia-Manero G; Patijn GA; Gotley DC; Bhardwaj V; Shureiqi I; Sen S; Multani AS; Welsh J; Yamamoto K; Taniguchi I; Song MA; Gallinger S; Casey G; Thibodeau SN; Le Marchand L; Tiirikainen M; Mani SA; Zhang W; Davuluri RV; Mimori K; Mori M; Sieuwerts AM; Martens JW; Tomlinson I; Negrini M; Berindan-Neagoe I; Foekens JA; Hamilton SR; Lanza G; Kopetz S; Fodde R; Calin GA
    Genome Res; 2013 Sep; 23(9):1446-61. PubMed ID: 23796952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knockdown of Long Noncoding RNA CCAT2 Suppresses Malignant Phenotype in Human Laryngeal Squamous Cell Carcinoma.
    Li M; An J; Ren H; Gui J; Wang H; Wu S; Wu R; Xiao H; Wang L
    Bull Exp Biol Med; 2023 Sep; 175(5):673-680. PubMed ID: 37874495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CCAT1 promotes triple-negative breast cancer progression by suppressing miR-218/ZFX signaling.
    Han C; Li X; Fan Q; Liu G; Yin J
    Aging (Albany NY); 2019 Jul; 11(14):4858-4875. PubMed ID: 31310241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression of colon cancer associated transcript1 (CCAT1) along the colonic adenoma-carcinoma sequence.
    Alaiyan B; Ilyayev N; Stojadinovic A; Izadjoo M; Roistacher M; Pavlov V; Tzivin V; Halle D; Pan H; Trink B; Gure AO; Nissan A
    BMC Cancer; 2013 Apr; 13():196. PubMed ID: 23594791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silencing of long non-coding RNA CCAT2 depressed malignancy of oral squamous cell carcinoma via Wnt/β-catenin pathway.
    Ma Y; Hu X; Shang C; Zhong M; Guo Y
    Tumour Biol; 2017 Jul; 39(7):1010428317717670. PubMed ID: 28671055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The functions and oncogenic roles of CCAT1 in human cancer.
    Liu Z; Chen Q; Hann SS
    Biomed Pharmacother; 2019 Jul; 115():108943. PubMed ID: 31078038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of CCAT2 promotes cell proliferation by repressing the P15 in breast cancer.
    Deng X; Zhao Y; Wu X; Song G
    Biomed Pharmacother; 2017 Jul; 91():1160-1166. PubMed ID: 28531944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA CCAT1 sponges miR-218-5p to promote EMT, cellular migration and invasion of retinoblastoma by targeting MTF2.
    Meng X; Zhang Y; Hu Y; Zhong J; Jiang C; Zhang H
    Cell Signal; 2021 Oct; 86():110088. PubMed ID: 34265414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNA CCAT1 promotes colorectal cancer progression by regulating miR-181a-5p expression.
    Shang A; Wang W; Gu C; Chen W; Lu W; Sun Z; Li D
    Aging (Albany NY); 2020 May; 12(9):8301-8320. PubMed ID: 32380476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long noncoding RNA CCAT1, which could be activated by c-Myc, promotes the progression of gastric carcinoma.
    Yang F; Xue X; Bi J; Zheng L; Zhi K; Gu Y; Fang G
    J Cancer Res Clin Oncol; 2013 Mar; 139(3):437-45. PubMed ID: 23143645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.